Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima P Porten

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Urology|January 11, 2011
The outcomes of perineal urethrostomy with preservation of the dorsal urethral plate and urethral blood supplyJeremy B Myers, Sima P Porten, Jack W McAninch
BJU International|August 18, 2009
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized diseaseSima P Porten, Matthew R Cooperberg, Peter R Carroll
Current Opinion in Urology|July 25, 2013
Should histologic variants alter definitive treatment of bladder cancer?Daniel L Willis, Sima P Porten, Ashish M Kamat
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2019
Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder CancerSamuel L Washington, John Neuhaus, Maxwell V Meng, et al.
Clinical Genitourinary Cancer|February 26, 2019
Determinants of Guideline-Based Treatment in Patients With cT1 Bladder CancerAshwin S Balakrishnan, Samuel L Washington, Maxwell V Meng, et al.
The Journal of Urology|April 20, 2010
Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formersBrian H Eisner, Sima P Porten, Seth K Bechis, et al.
World Journal of Urology|February 25, 2011
The example of CaPSURE: lessons learned from a national disease registrySima P Porten, Matthew R Cooperberg, Badrinath R Konety, et al.
The Journal of Urology|February 23, 2010
The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formersBrian H Eisner, Sima P Porten, Seth K Bechis, et al.
BMC Urology|July 19, 2020
Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer DatabaseKyle B Zuniga, Samuel L Washington, Sima P Porten, et al.
The Urologic Clinics of North America|November 24, 2019
Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder CancerCarissa E Chu, Sima P Porten, Gary D Grossfeld, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Urology|January 11, 2011
The outcomes of perineal urethrostomy with preservation of the dorsal urethral plate and urethral blood supplyJeremy B Myers, Sima P Porten, Jack W McAninch
BJU International|August 18, 2009
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized diseaseSima P Porten, Matthew R Cooperberg, Peter R Carroll
Current Opinion in Urology|July 25, 2013
Should histologic variants alter definitive treatment of bladder cancer?Daniel L Willis, Sima P Porten, Ashish M Kamat
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2019
Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder CancerSamuel L Washington, John Neuhaus, Maxwell V Meng, et al.
Clinical Genitourinary Cancer|February 26, 2019
Determinants of Guideline-Based Treatment in Patients With cT1 Bladder CancerAshwin S Balakrishnan, Samuel L Washington, Maxwell V Meng, et al.
The Journal of Urology|April 20, 2010
Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formersBrian H Eisner, Sima P Porten, Seth K Bechis, et al.
World Journal of Urology|February 25, 2011
The example of CaPSURE: lessons learned from a national disease registrySima P Porten, Matthew R Cooperberg, Badrinath R Konety, et al.
The Journal of Urology|February 23, 2010
The role of race in determining 24-hour urine composition in white and Asian/Pacific Islander stone formersBrian H Eisner, Sima P Porten, Seth K Bechis, et al.
BMC Urology|July 19, 2020
Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer DatabaseKyle B Zuniga, Samuel L Washington, Sima P Porten, et al.
The Urologic Clinics of North America|November 24, 2019
Role of Indoleamine-2,3-Dioxygenase Inhibitors in Salvage Therapy for Non-Muscle Invasive Bladder CancerCarissa E Chu, Sima P Porten, Gary D Grossfeld, et al.
Pageof 9